The Record header image

Forward to a friend  |  Subscribe  |  The Record Archive  |  Contacts  |  bcbsm.com  |  Print this article

February 2025

Requirements, codes changed for some medical benefit drugs

Blue Cross Blue Shield of Michigan and Blue Care Network encourage proper utilization of high-cost medications that are covered under medical benefits. As part of this effort, we maintain comprehensive lists of requirements for our members.

In October, November and December 2024, we added requirements for some medical benefit drugs. These requirements went into effect on various dates. In addition, one drug was assigned a new HCPCS code.

Changes in requirements

For Blue Cross commercial and BCN commercial members: We added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

J3590

Aucatzyl® IV

Obecabtagene autoleucel

J3590

Hympavzi™ SC

Marstacimab-hncq

J3590

Imuldosa™ IV and SC

Ustekinumab-srlf

J3590

Kebilidi™

Eladocagene exuparvovec-tneq

J3590

Otulfi™

Ustekinumab-aauz

J1628

Tremfya® IV

Guselkumab

For Medicare Plus Blue℠ and BCN Advantage℠ members: We added prior authorization requirements for the following drugs:

HCPCS code

Brand name

Generic name

For dates of service on or after

J3590

PiaSky™

Crovalimab-akkz

Oct. 1, 2024

J3590

Tecelra®

Afamitresgene autoleucel

Oct. 1, 2024

Q5136

Jubbonti®

Denosumab-bbdz

Nov. 3, 2024

Q5138

Wezlana™

Ustekinumab-bbdz

Nov. 3, 2024

J3590

Aucatzyl®

Obecabtagene autoleucel

Nov. 21, 2024

J1628

Tremfya® IV

Guselkumab

Dec. 2, 2024

Code change

The table below shows the HCPCS code change that was effective October 2024 for medical benefit drugs managed by Blue Cross and BCN:

New HCPCS code

Brand name

Generic name

Q5135

Tyenne®

Tocilizumab-aazg

Drug lists

For additional details, see the following drug lists:

These lists are also available on the following pages of the ereferrals.bcbsm.com website:

Additional information about these requirements

We communicated these changes previously through provider alerts. Those alerts contain additional details.

You can view the provider alerts on ereferrals.bcbsm.com and on our Provider Resources site, which is accessible through our provider portal at availity.com.**

Additional information for Blue Cross commercial groups

For Blue Cross commercial groups, authorization requirements apply only to groups that participate in the standard commercial Medical Drug Prior Authorization Program for drugs administered under medical benefits. To determine whether a group participates in the prior authorization program, see the Specialty Pharmacy Prior Authorization Master Opt-in/out Group List. A link to this list is also available on the Blue Cross Medical Benefit Drugs page of the ereferrals.bcbsm.com website.

Note: Blue Cross and Blue Shield Federal Employee Program® members and UAW Retiree Medical Benefits Trust non-Medicare members don't participate in the standard prior authorization program.

Reminder

An authorization approval isn’t a guarantee of payment. Health care providers need to verify eligibility and benefits for members.

**Blue Cross Blue Shield of Michigan and Blue Care Network don’t own or control this website.

Availity® is an independent company that contracts with Blue Cross Blue Shield of Michigan and Blue Care Network to offer provider portal and electronic data interchange services.

No portion of this publication may be copied without the express written permission of Blue Cross Blue Shield of Michigan, except that BCBSM participating health care providers may make copies for their personal use. In no event may any portion of this publication be copied or reprinted and used for commercial purposes by any party other than BCBSM.

*CPT codes, descriptions and two-digit numeric modifiers only are copyright 2024 American Medical Association. All rights reserved.